Doxorubicin (Intezyne Technologies)

N/A

Report date: 2026/01/26 13:50:20

Base Information

Drug NameDoxorubicin (Intezyne Technologies)
Drug Alias NameDaunorubicinDoxorubicin (Intezyne Technologies)Daunorubicin (Intezyne Technologies)DoxorubicinIT-143
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsDNA intercalators
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntezyne Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntezyne Technologies Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A